Interferon-beta for multiple sclerosis: Long-term benefits?
Rudick
Richard A
RA
Cutter
Gary
G
D004185:Disability Evaluation; D004333:Drug Administration Routes; D006801:Humans; D007155:Immunologic Factors / Q000191:economics / Q000627:therapeutic use*; D016899:Interferon-beta / Q000191:economics / Q000627:therapeutic use*; D008137:Longitudinal Studies; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics; D012720:Severity of Illness Index
D007155:Immunologic Factors; D016899:Interferon-beta